Status:

COMPLETED

Cell Phone Technology Targeting ART Adherence and Drug Use

Lead Sponsor:

University of California, Los Angeles

Collaborating Sponsors:

National Institute on Drug Abuse (NIDA)

Conditions:

HIV

Opioid Abuse

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The objective of the current research is to improve treatment for injection opioid users by augmenting pharmacotherapy with an innovative text-messaging strategy to promote relapse prevention skills, ...

Detailed Description

the specific aims of this research are 1) To develop and refine, with user feedback, a cognitive behavioral therapy-based text-messaging intervention (TXT-CBT) for HIV-infected adults with opioid depe...

Eligibility Criteria

Inclusion

  • Inclusion criteria for participants in both Phase I and Phase II will be:
  • Age 18 or older;
  • DSM-IV diagnosis of Opioid Dependence;
  • HIV-infected serostatus;
  • Able to provide informed consent;
  • Willing and able to participate in study procedures,
  • Good general health or, in the case of a medical/psychiatric condition needing ongoing treatment, potential participant should be under the care of a physician who provides documented willingness to continue participant's medical management and coordinate care with the study physicians.
  • Exclusion Criteria:
  • Lack of proficiency in English;
  • Currently homeless (unless residing in a recovery home for which contact information can be provided);
  • Dependence on an illicit substance for which medical detoxification is imminently needed.
  • Presence of clinically significant psychiatric symptoms as assessed by MINI, such as psychosis, acute mania, or suicide risk that would require immediate treatment or make study compliance difficult.
  • \-

Exclusion

    Key Trial Info

    Start Date :

    December 1 2012

    Trial Type :

    INTERVENTIONAL

    Allocation :

    ACTUAL

    End Date :

    January 1 2016

    Estimated Enrollment :

    62 Patients enrolled

    Trial Details

    Trial ID

    NCT01884233

    Start Date

    December 1 2012

    End Date

    January 1 2016

    Last Update

    April 29 2022

    Active Locations (1)

    Enter a location and click search to find clinical trials sorted by distance.

    Page 1 of 1 (1 locations)

    1

    UCLA Isap Ocrc

    Los Angeles, California, United States, 90025

    Cell Phone Technology Targeting ART Adherence and Drug Use | DecenTrialz